Approval based on a comprehensive submission package including efficacy and safety data approximately six months after second dose SPIKEVAX has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union,…
ITHACA, NY / ACCESSWIRE / January 10, 2022 / Odyssey Semiconductor Technologies, Inc. (OTCQB: ODII), a Gallium Nitride (“GaN”) semiconductor device company developing innovative high-voltage, vertical power switching components, today provided additional information related to…
DALLAS, TX / ACCESSWIRE / December 29, 2021 / There’s a certain amount of skepticism that goes along with trying a new business, and for good reason. Without enough information on a business, consumers don’t…
Fortius Capital Foundation’s New Solution Gives Entrepreneurs the Chance To Earn From Fintech Without Any Prior Knowledge. DUBAI, UAE / ACCESSWIRE / December 13, 2021 / The Bitcoin ETF Trading Challenge, operated by Fortius Capital…
(This release corrects the release that was posted on November 22, 2021 with updates regarding the Partnership details.) HOUSTON, TX / ACCESSWIRE / November 29, 2021 / BitWallet has partnered with Baanx in an agreement…
COLLEGE STATION, TX / ACCESSWIRE / December 2, 2021 / Enzolytics wishes to recognize and acknowledge World AIDS Day – a day to call attention to the continued need for a more effective treatment for…
DALLAS, TX / ACCESSWIRE / November 22, 2021 / B-Multi-family properties come in abundance in America, and it serves a particular market. As a result, many families have been open to renting and leasing apartments…
NEW YORK, NY / ACCESSWIRE / November 17, 2021 / Becoming a successful entrepreneur not only takes a lot of dedication and perseverance but also requires the mastery of certain technical skills. Unfortunately, as it…
Kai Medical Laboratory is Approved to Administer the Pfizer and Janssen Vaccines and Opens COVID-19 Vaccine Drive-Through VANCOUVER, BC / ACCESSWIRE / November 8, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an…
AXON presented results from its Phase II Clinical Study for AADvac1, vaccine against Alzheimer’s presented at Eurotau2021AXON demonstrated that vaccination-induced antibodies can stop the interaction and spreading of pathological tau species and protect the brain…
